Climb Bio is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. Our product candidates include, budoprutug, an anti-CD19 monoclonal antibody that presents us with an exciting opportunity given its broad potential applicability across a number of B-cell mediated diseases, including primary membranous nephropathy, systemic lupus erythematosus, and immune thrombocytopenia and CLYM116, an anti-APRIL monoclonal antibody in development for IgA nephropathy. At Climb Bio, our team has a knack for seeing what no one else sees—and a drive to achieve results no one expects. We believe that our combined strength conquers any summit, and our core values – Build Trust, Decide & Commit, Accelerate Impact, and Mark the Moment – guide how we work, collaborate and innovate. They reflect our commitment to patients, each other, and the pursuit of transformative science. We are seeking a highly motivated Associate Director/Director, Clinical Program Lead to serve as the operational leader for the CLYM116 program. Reporting to the VP, Clinical Operations, this role holds accountability for translating clinical development strategy into executable operational plans and for driving compliant, on-time, on-budget execution across all CLYM116 studies. As the operational engine behind a priority asset advancing toward late-stage development, this leader is critical to Climb Bio's ability to scale its clinical portfolio and deliver for patients.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level